$2.70+0.01 (+0.37%)
Sensus Healthcare, Inc.
Sensus Healthcare, Inc. in the Healthcare sector is trading at $2.70 with a market capitalization of $46M. Wall Street consensus targets $5.75 (4 analysts), implying a +113.0% move over the next 12 months. The stock is currently near its 52-week low of $2.66, remaining 30.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 9 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...
Sensus Healthcare’s fair value estimate has been trimmed from US$6.88 to US$5.75, putting a sharper spotlight on what analysts think the stock is worth today. That shift reflects a mix of optimism and caution, as recent research weighs the SRT-100/Vision platform and 2026 reimbursement changes against execution risk and timing. Read on to see how to interpret these updated targets and what to watch as the story continues to evolve. Stay updated as the Fair Value for Sensus Healthcare shifts...
Sensus Healthcare (NASDAQ:SRTS) said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year due largely to the absence of sales to its historically largest customer. Chairman and Chief Exec
Joining me from Sensus Healthcare, Inc. are Joseph C. Sardano, Chairman and Chief Executive Officer, Michael J. Sardano, President, Chief Commercial Officer and General Counsel, and Javier Rampolla, Chief Financial Officer. As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws.
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now